RESEARCH MEDICAL CENTER (AMEND-3) — History
CCN 260027 | 3-year financial timeline | COVID resilience: 41/100
🛡️ Public data only — no PHI permitted on this instance.
$487M
Latest Revenue (FY2022)
+4.0%
Revenue CAGR (3yr)
-5.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $450M | $489M | $487M | -0.3% | +4.0% |
| Operating Expenses | $451M | $486M | $512M | +5.4% | +6.6% |
| Operating Margin | -0.2% | 0.6% | -5.2% | -1010.5% | +0.0% |
| Net Income | $-1M | $3M | $-25M | -1007.6% | +0.0% |
| Licensed Beds | 368 | 343 | 337 | -1.7% | -4.3% |
| Total Patient Days | 89,878 | 87,855 | 84,089 | -4.3% | -3.3% |
| Medicare Day % | 25% | 23% | 20% | -13.0% | -11.9% |
| Medicaid Day % | 15% | 16% | 17% | +1.8% | +6.1% |
COVID Impact & Recovery
Resilience Score: 41/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +8.2% ($450M → $487M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.0%
This Hospital
+7.6%
State Avg
Latest Margin
-5.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $506M | -7.7% |
| FY2024 (proj) | $524M | -10.1% |
| FY2025 (proj) | $543M | -12.6% |